Literature DB >> 10615066

Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro.

E Sato1, K L Simpson, M B Grisham, S Koyama, R A Robbins.   

Abstract

Peroxynitrite, an oxidant generated by the interaction between superoxide and nitric oxide (NO), has been implicated in the etiology of numerous disease processes. Several studies have shown that peroxynitrite-induced protein nitration may compromise enzyme and protein function. We hypothesized that peroxynitrite may regulate cytokine function during inflammation. To test this hypothesis, the eosinophil chemotactic responses of eotaxin incubated with and without peroxynitrite were evaluated. Peroxynitrite attenuated eotaxin-induced eosinophil chemotactic activity (ECA) in a dose-dependent manner (P < 0.05). The inhibitory effects were not significant on ECA induced by leukotriene B(4) or complement-activated serum incubated with peroxynitrite. The reducing agents deferoxamine and dithiothreitol reversed the ECA inhibition by peroxynitrite, and exogenous L-tyrosine abrogated the inhibition by peroxynitrite. PAPA-NONOate (an NO donor) or a combination of xanthine and xanthine oxidase to generate superoxide did not show an inhibitory effect on ECA induced by eotaxin. In contrast, 3-morpholinosydnonimine, a peroxynitrite generator, caused a concentration-dependent inhibition of ECA by eotaxin. Consistent with its capacity to reduce ECA, peroxynitrite treatment reduced eotaxin binding to eosinophils. Nitrotyrosine was detected in the eotaxin incubated with peroxynitrite. These findings are consistent with nitration of tyrosine by peroxynitrite with subsequent inhibition of eotaxin binding to eosinophils and a reduction in ECA. These data demonstrate that peroxynitrite modulates the eosinophil migration by eotaxin, and suggest that oxidants may play an important role in regulation of eotaxin-induced eosinophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10615066     DOI: 10.1165/ajrcmb.22.1.3644

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  4 in total

Review 1.  The unique structural and functional features of CXCL12.

Authors:  Rik Janssens; Sofie Struyf; Paul Proost
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

2.  Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.

Authors:  Sara M Thomazzi; Juliana Moreira; Sisi Marcondes; Gilberto De Nucci; Edson Antunes
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

3.  Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity.

Authors:  Rik Janssens; Daiane Boff; Pieter Ruytinx; Anneleen Mortier; Vincent Vanheule; Olav Larsen; Viktorija Daugvilaite; Mette M Rosenkilde; Sam Noppen; Sandra Liekens; Dominique Schols; Ingrid De Meester; Ghislain Opdenakker; Sofie Struyf; Mauro M Teixeira; Flávio A Amaral; Paul Proost
Journal:  Front Immunol       Date:  2018-08-28       Impact factor: 7.561

4.  Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.

Authors:  Letícia Lintomen; Gilberto Franchi; Alexandre Nowill; Antonio Condino-Neto; Gilberto de Nucci; Angelina Zanesco; Edson Antunes
Journal:  BMC Pulm Med       Date:  2008-08-12       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.